| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Capecitabine is rapidly absorbed through the intestinal mucosa after oral administration, and then converted into an inactive intermediate 5'-deoxy-5'fluorocytidine by carboxylesterase in the liver, and then converted into an inactive intermediate by cytidine deaminase in the liver and tumor tissue. 5'-deoxy-5' fluorouridine is finally catalyzed by thymidine phosphorylase to fluorouracil (5-FU) in tumor tissue.
Clinical studies have shown that the concentration of 5-FU in tumor tissue after oral administration of this product is significantly higher than that in blood and muscle. The curative effect on a variety of animal tumors is significantly higher than that of 5-FU. This product has a synergistic effect with a variety of anti-tumor drugs
|
English name Capecitabine CAS No. 158798-73-3 Molecular weight 359.350 Density 1.5±0.1 g/cm3 Molecular formula C15H22FN3O6 |
){kind=link}